For this reason, the treatment of immune checkpoint inhibitors (ICIs) combined with PD-1 or PD-L1, especially for cancers such as non-small cell lung cancer, has shown remarkable efficacy, and may also be of great significance for the treatment of lung cancer caused by TB (46) (Figure 3). This evidence concerns the gene CD274 and lung carcinoma.